BioCentury
ARTICLE | Financial News

Adrenomed raises €24M series D

November 30, 2018 7:04 PM UTC

Adrenomed AG (Hennigsdorf, Germany) raised €24 million ($27.3 million) in a series D round led by new investors Wellington Partners and HBM Healthcare Investments, with participation from existing investors ILB, ExpoCapital GmbH and company founders. The company said undisclosed private investors also participated...

BCIQ Company Profiles

Adrenomed AG